Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial.

@article{Lambalk2006TreatmentWT,
  title={Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial.},
  author={Cornelis B Lambalk and Arthur L. Leader and François Olivennes and Margo R. Fluker and Anders Nyboe Andersen and Jo̸rgen Ingerslev and Yakoub Khalaf and C. Avril and Jo{\"e}lle C. Belaisch-Allart and Roger Roulier and Bernadette Mannaerts},
  journal={Human reproduction},
  year={2006},
  volume={21 3},
  pages={
          632-9
        }
}
BACKGROUND This study was designed to assess whether the use of ganirelix in women undergoing stimulated IUI could prevent the occurrence of premature LH rises and luteinization (LH+progesterone rises). METHODS Women of infertile couples, diagnosed with unexplained or male factor infertility, were randomized to receive either ganirelix (n=103) or placebo (n=100) in a double-blind design. All women were treated with an individualized, low-dose rFSH regimen started on day 2-3 of cycle… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 30 CITATIONS, ESTIMATED 50% COVERAGE

61 Citations

0510'10'13'16'19
Citations per Year
Semantic Scholar estimates that this publication has 61 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
SHOWING 1-10 OF 22 REFERENCES

Similar Papers

Loading similar papers…